Nephros (NASDAQ:NEPH – Get Free Report) and Tecan Group (OTCMKTS:TCHBF – Get Free Report) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, profitability, analyst recommendations, institutional ownership, dividends, valuation and earnings.
Analyst Recommendations
This is a breakdown of recent recommendations for Nephros and Tecan Group, as reported by MarketBeat.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Nephros | 0 | 0 | 0 | 0 | N/A |
Tecan Group | 0 | 0 | 0 | 0 | N/A |
Institutional & Insider Ownership
Valuation and Earnings
This table compares Nephros and Tecan Group’s top-line revenue, earnings per share (EPS) and valuation.
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
Nephros | $14.24 million | 1.62 | -$1.58 million | ($0.15) | -14.60 |
Tecan Group | N/A | N/A | N/A | $4.27 | 93.68 |
Tecan Group has lower revenue, but higher earnings than Nephros. Nephros is trading at a lower price-to-earnings ratio than Tecan Group, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares Nephros and Tecan Group’s net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
Nephros | -11.06% | -18.25% | -14.29% |
Tecan Group | N/A | N/A | N/A |
Summary
Tecan Group beats Nephros on 6 of the 8 factors compared between the two stocks.
About Nephros
Nephros, Inc., a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. The company also manufactures and sells water filters that enhance the taste and odor of water, as well as reduce biofilm, cysts, particulates, and scale build-up in downstream equipment. It markets its products to food service, hospitality, convenience store, and health care markets, as well as medical institutions. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.
About Tecan Group
Tecan Group AG provides laboratory instruments and solutions for pharmaceutical, biotechnology and in-vitro diagnostic companies, university research departments, and diagnostic and other laboratories. It operates through Life Sciences Business and Partnering Business segments. The company offers liquid handling and automation, microplate readers and washers, consumables, NGS reagents, immunoassays and antibodies, and software; and Tecan Labwerx, an automation solution. It provides PARAMIT, a contract design and manufacturing service. The company operates in Switzerland, Europe, Other European countries, North America, Asia, and internationally. Tecan Group AG was founded in 1980 and is headquartered in Männedorf, Switzerland.
Receive News & Ratings for Nephros Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nephros and related companies with MarketBeat.com's FREE daily email newsletter.